Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabienne Huber

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Praxis|September 29, 2021
[CME Dermatology 24: Porokeratosis]Fabienne Huber, Stephan Lautenschlager
Praxis|October 27, 2021
[CME Dermatology 24/Answers: Porokeratosis]Fabienne Huber, Stephan Lautenschlager
Journal of Travel Medicine|February 3, 2018
Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel ClinicsFabienne Huber, Benoît Ehrensperger, Christoph Hatz, et al.
Neuro-Oncology Practice|August 7, 2019
Complementary and alternative medicine use by glioma patients in SwitzerlandGünter Eisele, Ulrich Roelcke, Katrin Conen, et al.
Frontiers in Medicine|March 18, 2021
Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen TherapyMaya Bisang, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
Scientific Reports|October 14, 2021
Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trialSophia Gutweniger, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
JAMA Network Open|June 23, 2020
Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical TrialLu Tan, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 23, 2023
Exercise Performance of Lowlanders with Chronic Obstructive Pulmonary Disease Acutely Exposed to 2048 m: A Randomized Cross-Over TrialKonstantinos Bitos, Tobias Kuehne, Tsogyal D Latshang, et al.
Frontiers in Physiology|July 26, 2021
Effect of Nocturnal Oxygen Therapy on Daytime Pulmonary Hemodynamics in Patients With Chronic Obstructive Pulmonary Disease Traveling to Altitude: A Randomized Controlled TrialMona Lichtblau, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
Experimental Physiology|July 22, 2025
Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 mDominic Gilliand, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Praxis|September 29, 2021
[CME Dermatology 24: Porokeratosis]Fabienne Huber, Stephan Lautenschlager
Praxis|October 27, 2021
[CME Dermatology 24/Answers: Porokeratosis]Fabienne Huber, Stephan Lautenschlager
Journal of Travel Medicine|February 3, 2018
Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel ClinicsFabienne Huber, Benoît Ehrensperger, Christoph Hatz, et al.
Neuro-Oncology Practice|August 7, 2019
Complementary and alternative medicine use by glioma patients in SwitzerlandGünter Eisele, Ulrich Roelcke, Katrin Conen, et al.
Frontiers in Medicine|March 18, 2021
Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen TherapyMaya Bisang, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
Scientific Reports|October 14, 2021
Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trialSophia Gutweniger, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
JAMA Network Open|June 23, 2020
Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical TrialLu Tan, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 23, 2023
Exercise Performance of Lowlanders with Chronic Obstructive Pulmonary Disease Acutely Exposed to 2048 m: A Randomized Cross-Over TrialKonstantinos Bitos, Tobias Kuehne, Tsogyal D Latshang, et al.
Frontiers in Physiology|July 26, 2021
Effect of Nocturnal Oxygen Therapy on Daytime Pulmonary Hemodynamics in Patients With Chronic Obstructive Pulmonary Disease Traveling to Altitude: A Randomized Controlled TrialMona Lichtblau, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
Experimental Physiology|July 22, 2025
Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 mDominic Gilliand, Tsogyal D Latshang, Sayaka S Aeschbacher, et al.
Pageof 2